Postdoctoral researcher. T-cell enthusiast. Still getting into mice’s head and still fighting GBM, now at @Elinav_DKFZ
Heidelberg, Germany
Joined June 2021
- Tweets36
- Following210
- Followers103
- Likes957
Pinned Tweet
Proud to say part of my PhD research in #CART #Immunotherapy was finaly published with @SpringerNature in @NatureComms. This research is nothing but the product of great team work, thanks to @LiatNoori @DfmLab and lab!
Design and anti-tumor efficacy of p32-directed CAR-T cells for glioblastoma treatment.
nature.com/articles/s41467-0…
#CancerResearch @DfmLab @TelAvivUni @of_sagol
Ignacio Mastandrea retweeted
👩🎓So proud of our very first #PhD @aureliasaftien for successfully defending her thesis on #fungi 🍄.
Thanks Aurelia for all the awesome science, legendary memes, and shaping the @Elinav_DKFZ division PhD student culture. Congrats Dr. Saftien! 🎉
🥳🥳🥳 – at Israel
For anyone who's spent way too long creating posters in PPT at 4000% zoom🔎😭
BioRender Poster Builder is officially launched! Magically resize columns, customize colors, vector export, and more🙌🏽 It's free to use and currently in beta. Lmk your thoughts! app.biorender.com/#new-poste…
Ignacio Mastandrea retweeted
We came for the science, we stayed for the beer!
Amazing days at #icle22
#TogetherAtICLE #LymphocyteEngineering – at Munich, Germany
Comparto por acá la entrevista que tuve el placer de hacer con @JanaBeris1 acerca de mi vida en Israel como estudiante extranjero.
Feels good to be doing this again F2F! Had an amazing time at #ISGCT2022 listening to dome great talks and presenting my current work in boosting CAR-T cell efficacy by TME modulation.
This is amazing!
An illustration I created to represent the idea of CAR-T cell therapy: a type of cancer therapy in which a patient's immune cells are engineered to fight their tumor. The idea was to represent a CAR-T cell conducting "surveillance" to find tumors to eliminate. #SciArt
Ignacio Mastandrea retweeted
We had the most amazing @DfmLab activity: glass blowing workshop at Caesarea. Fun, good vibe, and a magical scenery.
Congratulations, Dino 🥳🥳 We are all proud of you!
I can’t believe it is finally my turn…
I am now a tenured professor 🎉🥂 Thanks to all my family, colleagues, friends and especially to all @DfmLab members. More celebrations to come…
Happy to see the media coverage this work from our lab has been recently having 🥳 Cheers @PrernaMagod @DfmLab 🥂
Researchers led by Dr. @DfmLab of @TelAvivUni discovered that some #immune #cells that fight #braincancer can "switch sides" to help & protect the #tumor! This finding can boost treatments effectiveness against one of the deadliest types of brain cancer: lnkd.in/dhA4YaDw
Thanks Dino and everyone, it was an honor!
Congrats to my PhD student @IgnacioMasta and all the winners of this year’s Zvi and Esther Weinstain Graduate Student Award. So proud 👏🏻👏🏻
If you haven't checked it out make sure to check our lab's last publication in @CellReports. I feel proud of @PrernaMagod and the whole @DfmLab.
Don't miss details in how #GBM is capable of remotely regulating #neutrophils' phenotype.
cell.com/cell-reports/fullte…
Ignacio Mastandrea retweeted
Yeah! It's out 🍾🥂 Our contribution to "The neutrophil" fan club 😀 Systemic reprogramming and #neutrophil plasticity in #GBM. Great team work @PrernaMagod @IgnacioMasta @LiatNoori Lilach Agemy, Guy Shapira and @nshomron
cell.com/cell-reports/fullte…
Ignacio Mastandrea retweeted
Immunotherapy, developed by @TelAvivUni team led by Dr. @DfmLab, helps immune cells eliminate Glioblastoma #braincancer cells! Researchers generated p32 CAR T cells, that recognize & eliminate p32 expressing glioma cells & tumor derived endothelial cells lnkd.in/dNDg-kx
Ignacio Mastandrea retweeted
Design and anti-tumor efficacy of p32-directed CAR-T cells for glioblastoma treatment.
nature.com/articles/s41467-0…
#CancerResearch @DfmLab @TelAvivUni @of_sagol
Ignacio Mastandrea retweeted
P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas cancercommunity.nature.com/p…
Nice cartoon and "behind the paper" by @IgnacioMasta at @DfmLab
If you want to know more about the behind the scenes of our last publication in #CART #immunotherapy #glioblastoma check my post in Nature Portfolio Cancer Community. If not, just click to see the amazing illustration by Belén Mastandrea.
cancercommunity.nature.com/p…
Ignacio Mastandrea retweeted
It’s out!!🎉🥂 Delighted that our newly published #CART #Immunotherapy study describing the identification of a novel TAA in glioma, and the design of a p32-directed CAR-T is online. Wonderful team effort… so proud!
Design and anti-tumor efficacy of p32-directed CAR-T cells for glioblastoma treatment.
nature.com/articles/s41467-0…
#CancerResearch @DfmLab @TelAvivUni @of_sagol